Blog

It has been estimated that more than 50 million people have epilepsy around the world of whom more than 4.7 million live in the World Health Organization’s Eastern Mediterranean Region [1]. Despite the fact that epilepsy affects both men and women equally [2], delivering healthcare services for women with epilepsy is often faced by many specific women’s health related challenges [3]. These challenges often pertain to selecting the appropriate antiepileptic drugs (AEDs) for women of childbearing age because some AEDs were shown to be teratogenic, interact with sex hormones (pre- and post-menopause), reduce the efficacy of contraceptives, cause sexual dysfunction in women, reduce bone mass, affect breastfeeding, and many more [3].